Supplemental arginine above the requirement during suckling causes obesity and insulin resistance in rats Lila Otani, Tomomi Mori, Ayaka Koyama, Shin-Ichiro Takahashi, Hisanori Kato PII: DOI: Reference:
S0271-5317(16)00016-6 doi: 10.1016/j.nutres.2016.01.007 NTR 7597
To appear in:
Nutrition Research
Received date: Revised date: Accepted date:
5 October 2015 18 January 2016 25 January 2016
Please cite this article as: Otani Lila, Mori Tomomi, Koyama Ayaka, Takahashi Shin-Ichiro, Kato Hisanori, Supplemental arginine above the requirement during suckling causes obesity and insulin resistance in rats, Nutrition Research (2016), doi: 10.1016/j.nutres.2016.01.007
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Supplemental arginine above the requirement during suckling causes obesity and insulin resistance in rats
T
Lila Otani1, Tomomi Mori1, Ayaka Koyama1, Shin-Ichiro Takahashi2, and Hisanori Kato1 1
Animal Sciences, Graduate School of Agricultural and Life Sciences, The University of
SC
2
RI P
Food for Life, Organization for Interdisciplinary Research Projects, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan
MA NU
Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo, 113-8657, Japan
*Corresponding author: Prof. Hisanori Kato, Food for Life, Organization for Interdisciplinary Research Projects, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. Tel&Fax: +81-3-5841-1607 E-mail:
[email protected]
ED
Running title: Arginine supplementation and obesity
AC
CE
PT
Word count (not including title page, Abbreviations list and References): 5761
1
ACCEPTED MANUSCRIPT Abbreviations
T
5,10-CH3 THF: 5,10-methylenetetrahydrofolate, AUC: area under the curve, CT: computed
RI P
tomography, GH: growth hormone, IGF-1: insulin like growth factor-1, NO: nitric oxide,
SC
OGTT: oral glucose tolerance test, SAH: S-adenosylhomocysteine, SAM:
AC
CE
PT
ED
MA NU
S-adenosylmethionine, TG: triglyceride
2
ACCEPTED MANUSCRIPT Abstract
T
Nutrition in early life is important in determining susceptibility to adult obesity, and arginine
RI P
may promote growth acceleration in infants. We hypothesized that maternal arginine
SC
supplementation may promote growth in their pups and contribute to obesity and alteration of the metabolic system in later life. Dams and pups of Wistar rats were given a normal diet
MA NU
(15% protein) as a control (CN) or a normal diet with 2% arginine (ARG). Altered profiles of free amino acids in breast milk were observed in that the concentrations of threonine and glycine were lower in the ARG dams compared to the CN dams. The offspring of the CN and
ED
ARG dams were further subdivided into normal diet (CN-CN and ARG-CN) groups and a
PT
high-fat diet groups (CN-HF and ARG-HF). In response to the high-fat diet feeding, the
CE
visceral fat deposits were significantly increased in the ARG-HF group (although not
AC
compared to the CN-HF group); no difference was observed between the CN-CN and ARG-CN groups. The blood glucose and insulin levels after glucose loading were significantly higher in the ARG-HF group compared to the CN-HF group. The results suggest that the offspring of dams supplemented with arginine during lactation acquired increased susceptibility to a high-fat diet, resulting in visceral obesity and insulin resistance. The lower supply of threonine and glycine to pups may be one of the contributing causes to the programming of lifelong obesity risk in offspring. Our findings also indicated that maternal arginine supplementation during suckling causes obesity and insulin resistance in rats. 3
ACCEPTED MANUSCRIPT Key words: Postnatal nutrition, arginine, obesity, insulin sensitivity, breast milk, obesity,
AC
CE
PT
ED
MA NU
SC
RI P
T
metabolic syndrome
4
ACCEPTED MANUSCRIPT 1. Introduction
T
Metabolic syndrome — which includes central obesity, insulin resistance, and
RI P
hypertension — has a multifactorial etiology that involves a series of complex interactions
SC
between individual dietary habits and the genetic background. The current prevalence of metabolic syndrome is a consequence of pervasive obesity. Increasing evidence indicates that
MA NU
the risk of obesity can be developmentally induced during the prenatal or postnatal period by unbalanced maternal nutrition. As such, alterations of nutrient delivery during early periods can significantly impact an individual’s susceptibility to obesity, diabetes and cardiovascular
CE
PT
ED
diseases later in life.
AC
The nursing period is an important critical window in the determination of the future metabolic system. Babies born small who experience rapid catch-up growth have been shown to tend to develop obesity in later life [1]. In addition, rapid weight gain during the first 3 months of life is associated with central adiposity and reduced insulin sensitivity in early adulthood, compared to slower weight gain [2]. Rapid early growth may thus be linked to adult obesity.
5
ACCEPTED MANUSCRIPT Singahal et al. suggested that low birth weight with rapid catch-up growth in infants is
T
associated with the feeding of formula milk [3, 4]. The disposition to obesity during the
RI P
suckling period has also been observed in animal models. In rats, the adult offspring of
SC
mothers that were over-nourished while suckling are susceptible to obesity despite a normal post-weaning diet [5, 6]. Overnutrition during pre-weaning also induced adiposity in
MA NU
young-adult baboons [7]. It was demonstrated that dietary arginine supplementation
ED
stimulated protein synthesis and accretion in the skeletal muscle of neonatal pigs [8, 9].
PT
Arginine is necessary for the optimal growth of young mammals including rats, pigs, and
CE
dogs [10–12]. It is one of the major sources of tissue proteins and the precursor of nitric oxide
AC
(NO), urea, polyamines, proline, glutamate, and agmatine [13]. Arginine is a well-known growth hormone (GH) stimulator, and GH is an important modulator of linear growth. However, little is known about the influence of arginine supplementation in early life on metabolic systems in later life. We hypothesized that excessive maternal arginine intake during the suckling period may promote early growth and cause metabolic changes in rat offspring. In the present study, we thus examined the effect of arginine supplementation on susceptibility to obesity and insulin resistance in rat offspring, as well as its effect on the composition of breast milk. Our findings demonstrated that excessive arginine 6
ACCEPTED MANUSCRIPT supplementation during the suckling period resulted in visceral obesity with insulin resistance
T
in offspring. This result suggests that additional care may be required regarding the arginine
SC
RI P
intake level in lactating women.
MA NU
2. Methods and materials 2.1. Animals
Eight pregnant (14 days) Wistar rats were purchased from Charles River Laboratories
ED
(Kanagawa, Japan). Rats were fed a commercial diet (MF-2, Oriental BioService) until
PT
delivery. After delivery, we randomly divided the dams and pups into two groups; the first
CE
was given a normal diet (15% protein diet) as a control group (CN, 4 dams in the group), and
AC
the second group was given a normal diet supplemented with 2% arginine, as the arginine-treated group (ARG, 4 dams per). All litters were culled to 8 pups on postnatal day 4. The mean body weight of the pups kept alive was similar in both litters. The dams and their pups were maintained under these conditions until weaning on day 21. After weaning, only the male offspring were studied and were placed in individual wire mesh cages (KN-615, Natsume Seisakusho. Tokyo). The size of cage was 750 mm wide × 210 mm long × 170 mm high.
7
ACCEPTED MANUSCRIPT
T
From 3 weeks of age, all animals were given a normal diet (15% protein diet). At 6 weeks of
RI P
age, the offspring in the CN and ARG groups were further divided into a normal diet group
SC
(15% protein, 12.5% calories from fat) and a high-fat diet group (15% protein, 35% calories from fat). The composition of each purified diet is described in Table 1.The number of rats in
MA NU
each group was 9–10. The offspring were weighed once a week. Their food intake was
ED
measured every day.
PT
An oral glucose tolerance test (OGTT) was performed when the pups reached 11 weeks of
CE
age, as follows. After a 16-h overnight fast, the rats were administered glucose (2 g kg–1)
AC
orally. Blood was collected from the tail vein in heparinized tubes chilled on ice. Blood glucose levels were measured using a commercial kit (Wako Pure Chemical Industries, Osaka, Japan), and insulin was measured using an insulin measurement kit (Morinaga Institute of Biological Science, Yokohama, Japan) following the manufacturer’s instructions. All samples were run in duplicate.
8
ACCEPTED MANUSCRIPT
T
At 12 weeks of age, the rats were anesthetized with pentobarbital (i.p., 30 mg·kg–1, Abbott,
RI P
North Chicago, IL) after a 1-h fast, and blood was taken from the carotid artery. All rats were
SC
euthanized by exsanguination under pentobarbital anesthesia immediately after the blood sampling. The liver, longissimus muscles and mesentery fats were excised, snap-frozen in
MA NU
liquid nitrogen and stored at −80°C until the analyses. All animal experiments were carried out in accord with the guidelines of the Animal Usage Committee of the Faculty of Agriculture, University of Tokyo, and were approved by the committee (Permission No.
CE
PT
ED
P09-375).
AC
2.2. Computed tomography scan analysis (body composition) For the computed tomography (CT) analysis of body fat mass, 11-week-old rats were anesthetized with isoflurane (3%–4%, 5 L/min, Dainippon Sumitomo Pharma, Osaka, Japan) and then placed in the chamber of a CT scanner for small animals (Latheta LCT-100, Hitachi Aloka Medical, Tokyo), according to the manufacturer's instructions. CT scans were performed at 2-mm intervals. Body fat composition images between thoracic vertebra T11 and S1 (the tip of the ischium) were used for the quantitative assessment with the Latheta software (ver. 3.00). The visceral adipose tissue was analyzed by assessing the fat content 9
ACCEPTED MANUSCRIPT within the visceral adipose tissue, and the subcutaneous adipose tissue and muscle were
2.3. Measurement of triglyceride (TG) in tissue
SC
RI P
T
distinguished and evaluated quantitatively.
MA NU
Lipids were extracted from the liver and muscle using the method described by Folch et al [14]. A piece of tissue was briefly homogenized in 4 ml of chloroform:methanol (2:1, v/v), after which 2% potassium chloride solution was added to the mixture and vortexed
ED
vigorously. The organic phase was transferred and dried in a vacuum. It was then dissolved in
PT
isopropanol, and samples were processed for analysis using a TG measurement kit (Wako),
AC
CE
following the manufacturer’s instructions. The measurements of TG were run in duplicate.
2.4. Amino acids and hormone concentrations in the breast milk and plasma of lactating dams or pups Breast milk and dam’s plasma were collected on day 14 of lactation from additional groups of dams fed the control diet (CN dams, n=5) or the 2% arginine-supplemented diet (ARG dams, n=5). After separation from the pups for 30 min, the dams were anesthetized with isoflurane (3%–4%, 5 L/min). Oxytocin (i.p., 0.1 ml, 2IU, Sigma-Aldrich Japan, Tokyo) was injected 10
ACCEPTED MANUSCRIPT into the dams to facilitate the collection of milk, and 0.5–1 ml milk was manually obtained
T
from all teats. Dam’s blood was also collected from the tail vein in heparinized tubes chilled
RI P
on ice. Pups were decapitated for the collection of trunk blood on day 14 or 21 of lactation.
SC
Samples were frozen at −80°C for further analysis. Whole milk samples were analyzed after sonication (Microson™ Ultrasonic cell disruptor, Misonix Inc., Farmingdale, NY) with 10
MA NU
bursts of 10-sec duration. Skimmed milk was prepared by centrifuging 500 μL of whole milk at 11,400×g, 4°C for 2 min. The fat layer was removed, and the aqueous phase was assayed
PT
ED
as described [15].
CE
The plasma and milk samples were each separately mixed with an equal volume of 3% (w/w)
AC
trichloroacetic acid. The mixture was centrifuged, and the supernatant was filtered through a 0.45-μm membrane prior to vialing as described [16]. The amino acid concentrations were measured by an automatic amino acid analyzer (L-8900; Hitachi, Tokyo). Single amino acid measurements were performed. The levels of the following components in plasma and milk were determined by commercial kits: leptin (R&D Systems, Minneapolis, MN), adiponectin (Otsuka Pharmaceuticals, Tokyo), insulin like growth factor-1 (IGF-1; R&D Systems), insulin (Morinaga Institute of Biological Science), and corticosterone (Assaypro, St. Charles, MO) according to the manufacturers' instructions. All hormone measurements were run in 11
ACCEPTED MANUSCRIPT
RI P
T
duplicate.
SC
2.5. Statistical analyses
The data are presented as the means ± standard error of the mean (SE). We used a statistical
MA NU
software package (Ekuseru-Toukei 2010, Social Survey Research Information Co.) for all data analyses. Statistical significance was calculated using Student’s t-test or a two-way analysis of variance (ANOVA) with Bonferroni and Tukey post hoc testing as indicated. A
CE
PT
ED
probability value of P < 0.05 was considered significant.
AC
We analyzed the values of body weight, CT-based body compositions, blood biochemical parameters, and liver and muscle TG in the pups fed the control diet or high-fat diet by performing a two-way ANOVA, followed by Bonferroni and Tukey post hoc tests to assess the differences between groups. The sample sizes were n=8 for the CN-CN group, n=9 for the ARG-CN group, n=9 for the CN-HF group, and n=10 for the ARG-HF group. The statistical differences in the body weight changes of the dams and pups at 6 weeks of age were assessed using Student’s t-test. The sample sizes were n=17 for the CN group and n=19 for the ARG group. The differences in the amino acid concentrations of the dams and pups were assessed 12
ACCEPTED MANUSCRIPT by Student’s t-test. The sample sizes of the dams were n=4 for the CN group and n=5 for the
T
ARG group. Two pups per litter were subjected to the analyses (CN group, n=8; ARG group,
3. Results 3.1. Growth and body composition
MA NU
SC
RI P
n=10).
At the end of the supplementation, the body weights were slightly lower in the pups of the
ED
arginine-supplemented group compared to the control group, although the difference was not
PT
significant (CN, 65 ± 1; ARG, 60 ± 2 g). After the further subdivision into the normal diet
CE
and high-fat diet groups at 6 weeks of age, no difference was observed in body weight
AC
between the CN-CN and ARG-CN groups under the normal diet feeding conditions (Fig. 1A). In contrast, in response to the high-fat diet, the body weights of the ARG-HF group were modestly increased (Fig. 1B), but the difference was not significant (p=0.07).
We also estimated the body fat mass of the rats’ abdominal and subcutaneous adipose tissue using a CT scan analysis on the abdominal area (Fig. 2). The subcutaneous fat volume was also increased in the ARG-HF group, although the difference was not significant (Fig. 2A,B). 13
ACCEPTED MANUSCRIPT The adipose volume was significantly increased in the intra-abdominal tissue of the rats in the
T
ARG-HF group compared to the CN-CN and ARG-CN groups (Fig. 2A,C). The visceral fat
RI P
weights (including mesenteric, epididymal, and retroperitoneal depots) were also
SC
significantly increased in the ARG-HF group (38.8 ± 1.6 g) compared to the CN-HF group (33.9 ± 1.2 g), as shown in Table 1. Under the normal diet feeding condition, the visceral fat
MA NU
weight was 30.9 ± 0.7 g in the CN-CN group, and 32.2 ± 1.6 g in the ARG-CN group (Table
PT
3.2 Glucose tolerance test
ED
1).
CE
Figure 3 shows the results of the oral glucose tolerance test (OGTT) in the 11-week-old rats.
AC
With the normal dietary intake, no difference was observed in glucose levels between the CN and ARG rats (Fig. 3A). The insulin levels after glucose loading were slightly higher in the ARG-CN group than in the CN-CN group (Fig. 3C). The data of the CN-HF group did not differ from those of the control animals (CN-CN) with respect to plasma glucose and insulin concentrations. On the other hand, in the high-fat diet groups, the rats that were supplemented with arginine during lactation had significantly higher levels of glucose and insulin levels after glucose loading (Fig. 3B,D). The total area under curve (AUC) for glucose and insulin is presented in Figure 3E,F. The insulin AUC was significantly increased in the ARG-HF group 14
ACCEPTED MANUSCRIPT compared to the CN-HF group. The glucose AUC was increased in the ARG-HF group, but
SC
RI P
T
the difference was not significant.
3.3. TG concentration in the plasma, liver and longissimus muscle
MA NU
Under the normal dietary conditions, the TG content in the longissimus muscle was significantly increased in the ARG-CN rats compared to the CN-CN rats (Fig. 4C). There was no significant difference between the ARG-CN and CN-CN groups or between the ARG-HF
ED
and CN-HF groups with respect to the liver TG (Fig. 4B). Figure 4C shows the significant
AC
CE
PT
difference between the ARG-HF and CN-HF groups with respect to plasma TG.
3.4. Amino acid concentrations in the breast milk and plasma of lactating dams or pups We measured the leptin, corticosterone, adiponectin, and insulin levels in the dams’ breast milk and plasma at 14 days of lactation. There were no significant differences in the profiles of these hormones (IGF-1, leptin, corticosterone, adiponectin, and insulin) between the CN and ARG groups, in the breast milk or in the plasma of the dams and pups (data not shown). Figure 5 shows the results of the measurement of free amino acid levels in the dams’ plasma and breast milk at 14 days of lactation. The arginine supplementation during lactation 15
ACCEPTED MANUSCRIPT produced an incremental increase of amino acids that are closely related to the urea cycle
T
(arginine, proline, ornithine) in dam’s plasma. The plasma levels of valine, methionine,
SC
RI P
isoleucine, and leucine were also higher in the arginine-supplemented group.
MA NU
Isoleucine was significantly increased in the breast milk from the dams fed the arginine-supplemented diet. Surprisingly, the threonine levels in the dams’ plasma were dramatically decreased by the maternal arginine supplementation. Moreover, the threonine
ED
concentrations in the breast milk were also decreased in the arginine-supplemented dams. The
PT
glycine concentration was also decreased in the breast milk of the ARG dams. Breast milk
CE
samples could not collected at 21 days of lactation. In the pups’ plasma, the threonine and
AC
lysine concentrations at 14 days of lactation were significantly decreased in the pups from dams fed the arginine-supplemented diet. However, the decreases in these amino acids were not found at 21 days of lactation.
16
ACCEPTED MANUSCRIPT 4. Discussion
T
We hypothesized that early postnatal arginine supplementation in rats induces rapid growth in
RI P
early life and affects the abdominal fat accumulation and insulin resistance in later life. In
SC
fact, our present findings indicate that maternal arginine supplementation during the suckling period did cause obesity and insulin resistance in the offspring, although it did not induce
MA NU
rapid growth.
ED
When the rats in our study were fed a normal diet, there was no apparent alteration in their
PT
metabolic status including their body weights and visceral fat weight, regardless of arginine
CE
supplementation. Since a high-calorie diet is often used to amplify metabolic abnormalities
AC
induced by pre- or postnatal dietary manipulations, we gave rats a high-fat diet (35% calories from fat) from 6 to12 weeks of age in the present study. A reduction of food intake, commonly observed in rats fed high-fat diets containing more than and is an important amino, is accompanied by a lower protein intake. It has been reported that a low-protein diet induces visceral fat accumulation in rats [17]. In our present findings, the interference of the food and protein consumption in rats fed the high-fat diet (35% calories from fat) can be excluded. Here, when rats were fed a high-fat diet, intra-abdominal fat was markedly accumulated in the offspring of dams fed the arginine-supplemented diet during the suckling period, but not 17
ACCEPTED MANUSCRIPT in the control offspring. In contrast, there was little difference in the subcutaneous fat
T
volumes among all groups. Accordingly, arginine supplementation during the suckling period
RI P
may be said to induce visceral obesity but not subcutaneous obesity in the offspring. Our
SC
findings demonstrated that abdominal fat accumulation was brought about as an alteration of the susceptibility to high-fat intake by arginine supplementation to dams and pups during the
MA NU
suckling period.
ED
There is growing evidence that the suckling period plays an important role in determining the
PT
later metabolic system. In humans, babies born small who undergo rapid catch-up growth
CE
have been shown to be more obese in later life [1]. In animal models, pre-weaning
AC
overnutrition induced adiposity in young-adult baboons [7] and rats [6]. It was also demonstrated that dietary arginine supplementation stimulates protein synthesis and accretion in skeletal muscle of neonatal pigs [8, 9, 18]. In the present study, arginine supplementation to dams did not induce rapid body weight increase in their pups. Moreover, the maternal arginine supplementation during the suckling period did not influence the levels of IGF-1, leptin corticosterone, adiponectin and insulin in the breast milk or plasma of the dams and pups. However, intra-abdominal fat was accumulated in the pups from dams fed an arginine-supplemented diet during the suckling period. Our results thus imply that adiposity 18
ACCEPTED MANUSCRIPT
RI P
T
and susceptibility to obesity may be determined by nutrient conditions in early life.
SC
Visceral obesity has been strongly associated with the development of major risk factors for insulin resistance [19–21]. In the present study, obese rats on a high-fat diet showed elevated
MA NU
plasma glucose levels after glucose administration compared to the control rats fed a normal-fat diet. Moreover, the high-fat feeding brought about high insulin secretion in the ARG-HF rats, but not in CN-HF rats. Therefore, the early arginine supplementation induced
ED
more severe insulin resistance under high-fat diet feeding. These results are in line with the
PT
established concept that adipocytes in the visceral adipose tissue are a stronger determinant of
AC
CE
insulin sensitivity than subcutaneous adipose tissue [22–24].
Regarding the rats on a normal diet, the insulin secretion of the ARG-CN rats was slightly higher after glucose loading, but no change in glucose levels was observed. In addition, ectopic fat accumulation was observed in the muscles of the ARG-CN rats. It has been reported that ectopic fat accumulation in the liver and skeletal muscle in humans is a critical determinant of insulin resistance, and may also predispose to the development of Type 2 diabetes [25, 26]. Arginine supplementation to young pigs increased the lipid content in the 19
ACCEPTED MANUSCRIPT longissimus muscle [18]. Taken together, these findings suggest that insulin resistance
T
potentially existed in the present arginine-supplemented group and was manifested by the
RI P
high-fat diet. As a result, high insulin secretion and high plasma glucose were found in the
MA NU
SC
ARG-HF group.
We also evaluated the amino acid concentrations in the dams’ breast milk and plasma. Arginine supplementation increased the arginine concentration in the dams’ plasma but not in
ED
their breast milk. Mateo et al. demonstrated that in sows’ breast milk, arginine
PT
supplementation did not increase the arginine concentration but did increase the plasma
CE
arginine concentration [27]. Arginine and lysine use the same membrane transporter system.
AC
In our study, however, arginine supplementation to suckling dams did not affect the dams’ plasma lysine concentration, and it did not affect the early growth pattern of their pups. Tan et al. reported that 1% arginine supplementation to pigs’ diet did not change the plasma lysine concentrations [28]. In a rat model, the oral arginine administration at 250 mg·kg−1 was reported to cause no abnormal histopathological changes [29]. It may be that arginine fed to the dams in our study was not directly transferred to their pups via maternal breast milk.
20
ACCEPTED MANUSCRIPT An unexpected finding of our investigation was that the Thr levels in the maternal plasma and
T
breast milk were greatly decreased by maternal arginine supplementation. The threonine
RI P
concentration was also decreased in the pups’ plasma. In a study of swine, the arginine
SC
supplementation of lactating sows significantly decreased the breast-milk threonine level at 7 days of lactation (Mateo et al. 2008). Threonine is one of the essential amino acids, and can
MA NU
be cleaved by threonine dehydrogenase to yield glycine and 5,10-methylenetetrahydrofolate (5,10-CH3 THF) [30, 31]. Threonine is involved in folate and the methionine cycle, and it is an important amino acid in controlling epigenetic modifications. Threonine and its catabolites
ED
control the ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH), which
PT
is a key factor for histone modifications [31]. Lower supplementation of threonine and lysine
CE
to pups may program higher susceptibility to a high-fat diet in later life by modifying the
AC
methylation status.
In the present study, no decrease in threonine concentration was found in the pups’ plasma at 21 days of lactation. It is likely that the pups obtained large proportions of nutrients from the purified diet at 21 days after birth, since the dams’ breast milk production was low and samples could not be collected at 21 days of lactation. We could not address how arginine supplementation changes the composition of breast milk or how such changes influence the 21
ACCEPTED MANUSCRIPT pups’ metabolism. The demand for arginine increases in specific conditions such as burns,
T
sepsis, hypertension, and angina pectoris [32]. Arginine seems to be safe and effective
RI P
therapy for many health conditions. A pair of studies demonstrated beneficial effects of
SC
arginine: an improvement of insulin resistance [33] and an anti-obesity effect [34]. However, we observed that the arginine supplementation during the suckling period led to higher
MA NU
susceptibility to a high-fat diet and obesity in offspring. Our data indicate that we need to be cautious in the application of arginine supplementation to pregnant and lactating women, and
PT
ED
that this matter should be investigated further.
CE
In conclusion, our present findings demonstrated that the offspring of dams supplemented
AC
with arginine during lactation acquired higher susceptibility to obesity and insulin resistance when fed a high-fat diet later in life. Interactions among these factors could lead to the alteration of susceptibility to diet-induced metabolic disorders. Growth acceleration was not observed in the pups from dams supplemented with arginine during suckling. In addition, the arginine supplementation to dams lowered the supply of threonine and glycine to their pups, and this may be one of the causes contributing to the programming of a lifelong risk of obesity in the offspring. Our study did not determine how arginine supplementation results in the changes that we observed. 22
T
ACCEPTED MANUSCRIPT
RI P
5. Acknowledgment
SC
This work was supported by the Program for the Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S.-I. Takahashi and H. Kato). The authors declare
AC
CE
PT
ED
MA NU
no conflict of interest.
23
ACCEPTED MANUSCRIPT 6. References
T
[1] Ong KK. Size at birth, postnatal growth and risk of obesity. Horm Res. 2006;65:65–9.
RI P
[2] Leunissen RWJ, Kerkhof GF, Stijnen T, Hokken-Koelega A. Timing and tempo of
SC
first-year rapid growth in relation to cardiovascular and metabolic risk profile in early adulthood. Jama-J Am Med Assoc. 2009;301:2234–42.
MA NU
[3] Singhal A, Cole TJ, Fewtrell M, Deanfield J, Lucas A. Is slower early growth beneficial for long-term cardiovascular health? Circulation. 2004;109:1108–13. [4] Singhal A, Lanigan J. Breastfeeding, early growth and later obesity. Obes Rev.
ED
2007;8:51–4.
PT
[5] Boullu-Ciocca S, Dutour A, Guillaume V, Achard V, Oliver C, Grino M. Postnatal
CE
diet-induced obesity in rats upregulates systemic and adipose tissue glucocorticoid
AC
metabolism during development and in adulthood—Its relationship with the metabolic syndrome. Diabetes. 2005;54:197–203. [6] Plagemann A, Heidrich I, Gotz F, Rohde W, Dorner G. Obesity and enhanced diabetes and cardiovascular risk in adult-rats due to early postnatal overfeeding. Exp Clin Endocrinol. 1992;99:154–8. [7] Lewis DS, Bertrand HA, Mcmahan CA, Mcgill HC, Carey KD, Masoro EJ. Preweaning food-intake influences the adiposity of young-adult baboons. J Clin Invest. 1986;78:899–905. [8] Kim SW, McPherson RL, Wu GY. Dietary arginine supplementation enhances the growth 24
ACCEPTED MANUSCRIPT of milk-fed young pigs. J Nutr. 2004;134:625–30.
T
[9] Yao K, Yin YL, Chu WY, Li ZQ, Deng D, Li TJ, et al. Dietary arginine supplementation
RI P
increases mTOR signaling activity in skeletal muscle of neonatal pigs. J Nutr.
SC
2008;138:867–72.
[10] Morris JG. Nutritional and metabolic responses to arginine deficiency in carnivores. J
MA NU
Nutr. 1985;115:524–31.
[11] Pau MY, Milner JA. Arginine deficiency during gestation and lactation in the rat. J Nutr. 1981;111:184–93.
ED
[12] Southern LL, Baker DH. Arginine requirement of the young pig. J Anim Sci.
PT
1983;57:402–12.
AC
1998;336:1–17.
CE
[13] Wu GY, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J.
[14] Folch J, Lees M, Stanley GHS. A Simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497–509. [15] Yamawaki N, Yamada M, Kan-no T, Kojima T, Kaneko T, Yonekubo A. Macronutrient, mineral and trace element composition of breast milk from Japanese women. J Trace Elem Med Bio. 2005;19:171–81. [16] Hsu JM, Anthony WL, Rider AA. Free amino acids in plasma and tissue of rats born to underfed dams. Proc Soc Exp Biol Med. 1975;148:1087–9. 25
ACCEPTED MANUSCRIPT [17] de Franca SA, dos Santos MP, Garofalo MAR, Navegantes LC, Kettelhut ID, Lopes CF,
RI P
adipose tissue of growing rats. Nutrition. 2009;25:1186–92.
T
et al. Low protein diet changes the energetic balance and sympathetic activity in brown
SC
[18] Yin YL, Tan B, Liu ZQ, Li XG, Xu HJ, Kong XF, et al. Dietary l-arginine
Amino Acids. 2009;37:169–75.
MA NU
supplementation increases muscle gain and reduces body fat mass in growing-finishing pigs.
[19] Defronzo RA, Ferrannini E. Insulin resistance—a multifaceted syndrome responsible for niddm, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular-disease.
ED
Diabetes Care. 1991;14:173–94.
PT
[20] Haffner SM. Insulin resistance, inflammation, and the prediabetic state. Am J Cardiol.
CE
2003;92:18j–26j.
AC
[21] Karter AJ, D'Agostino RB, Mayer-Davis EJ, Wagenknecht LE, Hanley AJG, Hamman RF, et al. Abdominal obesity predicts declining insulin sensitivity in non-obese normoglycaemics: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Obes Metab. 2005;7:230–8. [22] Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459–69. [23] Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR, et al. The concurrent 26
ACCEPTED MANUSCRIPT accumulation of intra-abdominal and subcutaneous fat explains the association between
T
insulin resistance and plasma leptin concentrations—Distinct metabolic effects of two fat
RI P
compartments. Diabetes. 2002;51:1005–15.
SC
[24] Frayn KN. Visceral fat and insulin resistance—causative or correlative? Brit J Nutr. 2000;83:S71–S7.
MA NU
[25] Komiya H, Mori Y, Yokose T, Kurokawa N, Horie N, Tajima N. Effect of intramuscular fat difference on glucose and insulin reaction in oral glucose tolerance test. J Atheroscler Thromb. 2006;13:136–42.
ED
[26] Yki-Jarvinen H. Ectopic fat accumulation: an important cause of insulin resistance in
PT
humans. J R Soc Med. 2002;95:39–45.
CE
[27] Mateo RD, Wu G, Moon HK, Carroll JA, Kim SW. Effects of dietary arginine
AC
supplementation during gestation and lactation on the performance of lactating primiparous sows and nursing piglets. J Anim Sci. 2008;86:827–35. [28] Tan B, Yin YL, Liu ZQ, Tang WJ, Xu HJ, Kong XF, et al. Dietary L-arginine supplementation differentially regulates expression of lipid-metabolic genes in porcine adipose tissue and skeletal muscle. J Nutr Biochem. 2011;22:441–5. [29] Motlekar NA, Srivenugopal KS, Wachtel MS, Youan BB. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation. J Pharm Pharmacol. 2006;58:591–8. 27
ACCEPTED MANUSCRIPT [30] Lefloch N, Obled C, Seve B. In-Vivo threonine oxidation rate is dependent on threonine
T
dietary supply in growing pigs fed low to adequate levels. J Nutr. 1995;125:2550–62.
RI P
[31] Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng YX, Teo RY, Ratanasirintrawoot S, et
SC
al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science. 2013;339:222–6.
MA NU
[32] Appleton J. Arginine: Clinical potential of a semi-essential amino acid. Altern Med Rev. 2002;7:512–22.
[33] Szulinska M, Musialik K, Suliburska J, Lis I, Bogdanski P. The effect of L-arginine
ED
supplementation on serum resistin concentration in insulin resistance in animal models. Eur
PT
Rev Med Pharmacol Sci. 2014;18:575–80.
CE
[34] Fu WJJ, Haynes TE, Kohli R, Hu JB, Shi WJ, Spencer TE, et al. Dietary L-arginine
AC
supplementation reduces fat mass in Zucker diabetic fatty rats. J Nutr. 2005;135:714–21.
28
ACCEPTED MANUSCRIPT 7. Figure legends
T
Fig. 1. Body weights of the rats supplemented with arginine during the lactation period fed a
RI P
normal diet (A) or high-fat diet (B) from 6 to 12 wks of age. Dams and their pups were given
SC
a normal diet (15% protein) as the control group (CN; open circles) or a normal diet with 2% arginine as the arginine-treated group (ARG; closed rectangles) from birth to weaning (3 wks
MA NU
of age). After weaning, both groups of rats were fed a normal diet. The offspring of the CN and ARG groups were further divided into a normal diet (15% protein, 12.5% calories from fat, CN-CN: n=8, ARG-CN: n=9) or a high-fat diet (15% protein, 35% calories from fat,
ED
CN-HF: n=9, ARG-HF: n=10) at 6 wks of age. Only male pups were used. Values are means
PT
± SE. Data were significantly different by a two-way ANOVA with Bonferroni and Tukey
AC
CE
post-hoc tests.
Fig. 2. CT-based body composition analysis of rats supplemented with arginine during lactation and fed a normal diet or a high-fat diet from 6 to 12 wks of age. Body fat composition images between T11 and S1 (the tip of the ischium) were used for the quantitative assessment. The representative CT images shown were taken at the L3 slice area (A). Pink and yellow areas represent the visceral and subcutaneous fat, respectively. The mean areas of subcutaneous (B) and visceral (C) fat are shown. The offspring of the CN and 29
ACCEPTED MANUSCRIPT ARG rats were further divided into a normal diet (15% protein, 12.5% calories from fat,
T
CN-CN: n=8, ARG-CN: n=9) or high-fat diet (15% protein, 35% calories from fat, CN-HF:
RI P
n=9, ARG-HF: n=10) at 6 wks of age. Only male pups were studied. Values are means ± SE.
SC
Data were significantly different using a two-way ANOVA with Bonferroni and Tukey
MA NU
post-hoc tests. *p<0.05, **p<0.01.
Fig. 3. The glucose and insulin levels after the glucose loading of rats supplemented with
ED
arginine during lactation fed a normal or high-fat diet from 6 to 12 wks of age. The OGTT in
PT
the CN (open circles) and ARG (closed rectangles) offspring was performed at 11 wks of age.
CE
After a 16-h overnight fast, 2 g kg–1 body weight of glucose was orally administered. A small
AC
amount of blood from the tail vein was collected at 0, 15, 30, 60 and 120 min after the glucose administration. Plasma glucose (A,B), insulin concentrations (C,D) and area under the curve (E,F) are shown. The offspring of the CN and ARG dams were further divided into a normal diet (15% protein, 12.5% calories from fat, CN-CN: n=8, ARG-CN: n=9) or high-fat diet (15% protein, 35% calories from fat, CN-HF: n=9, ARG-HF: n=10) at 6 wks of age. Only male pups were studied. Values are means ± SE. Data were significantly different by a two-way ANOVA with Bonferroni and Tukey post-hoc tests. *p<0.05, **p<0.01.
30
ACCEPTED MANUSCRIPT
T
Fig. 4. The longissimus muscle, liver and plasma TG content of the rats supplemented with
RI P
arginine during lactation fed a normal diet or high-fat diet from 6 to 12 wks of age. Blood
SC
was collected from the carotid artery after a 1-h fast at 12 wks of age. At the same time, the longissimus muscle and liver were obtained. Plasma TG (C), extracted lipid from the
MA NU
longissimus muscle (A) and liver (B) were measured using a TG measurement kit. The offspring of the CN and ARG groups were further divided into a normal diet (15% protein, 12.5% calories from fat, CN-CN: n=8, ARG-CN: n=9) or high-fat diet (15% protein, 35%
ED
calories from fat, CN-HF: n=9, ARG-HF: n=10) at 6 wks of age. Only male pups were
PT
studied. Values are means ± SE. Data were significantly different by a two-way ANOVA with
AC
CE
Bonferroni and Tukey post-hoc test. *p<0.05, **p<0.01.
Fig. 5. Free amino acid levels in the dams’ plasma and breast milk on day 14 of lactation. Dams’ plasma (A) and breast milk (B) were collected from dams fed the control diet (CN dams, n=5) or 2% arginine-supplemented diet (ARG dams, n=5). Values are means ± SE. Data were significantly different by Student’s t-test. *p<0.05.
31
ACCEPTED MANUSCRIPT Fig. 6. Free amino acid levels in the pups’ plasma on day 14 or 21 of lactation. Plasma was
T
collected from suckling pups from the dams fed the control diet (CN dams, n=4) or 2%
RI P
arginine-supplemented diet (ARG dams, n=5) on day 14 (A) or 21 (B) of lactation. Two pups
SC
per litter were subjected to the analysis (CN group, n=8; ARG group, n=10). Pups were decapitated for the collection of trunk blood for the determination of plasma free amino acids.
AC
CE
PT
ED
MA NU
Values are means ± SE. Data were significantly different by Student’s t-test. *p<0.05.
32
ACCEPTED MANUSCRIPT Table 1 Semi-purified ingredient composition of the diets fed to the rats 15% protein with 2% arginine
15% protein
High fat diet
12.5% 620.5 -
Casein1 DL-methionine Soy bean oil Vitamin mixture2 Mineral mixture2
175.0 2.5 20.0 10.0 40.0
175.0 2.5 20.0 10.0 40.0
175.0 2.5 20.0 10.0 40.0
Cellulose powder Choline chloride
100.0 2.0
100.0 2.0
100.0 2.0
T
Calories from fat Corn starch L-arginine Lard
g/kg 12.5% 600.5 20.0 -
RI P
SC
MA NU
Crude protein 85.71%
2
AIN-76 prescription (Oriental Bio Service, Inc., Tokyo, Japan)
AC
CE
PT
ED
1
33
35.0% 506.7 113.8
ACCEPTED MANUSCRIPT Table 2 Body weight gain and adipose tissue weight of the rats supplemented with arginine during lactation, fed a normal diet or high-fat diet from 6 to 12 wks of age
n=8 28 ± 1 a 225 ± 4 475 ± 6
n=9 24 ± 1b 226 ± 5 478 ± 12
RI P
n=9 27 ± 1 a 226 ± 3 475 ± 9
T
High fat diet CN-HF ARG-HF
SC
Food intake (g/day) Initial body weight (g) Final body weight (g)
Normal diet CN-CN ARG-CN
n=10 26 ± 1 ab 226 ±3 497 ± 9
Mesenteric depots fat (g) Visceral depots fat (g)
MA NU
Body weight gain (g) 250 ± 4 2491 ± 9 253 ± 8 272 ± 7.9 Liver weight (g) 17.2 ± 0.5 17.8 ± 0.6 16.4 ± 0.8 17.7 ± 0.4 Gastrocnemius muscle (g) 5.0 ± 0.1 4.8 ± 0.1 5.1 ± 0.2 4.9 ± 0.1 a a ab Epididymal depots fat (g) 12.3 ± 0.5 11.9 ± 0.6 13.0 ± 0.5 15.3 ±0.9 b Retroperitoneal depots fat (g) 11.8 ± 0.8 a 13.0 ± 0.8 a 13.7 ± 0.5 ab 15.6 ±0.5 b 6.8 ± 0.3 30.9 ± 0.7a
7.4 ± 0.5 32.2 ± 1.6a
7.2 ± 0.5 33.9 ± 1.2ab
8.0 ±0.5 38.8 ±1.6b
ED
Values are means ± SE. Data were significantly different by two-way ANOVA with
AC
CE
PT
Bonferroni and Tukey post-hoc test. Different superscript letters denote significant differences.
34
ED
MA NU
SC
RI P
T
ACCEPTED MANUSCRIPT
AC
CE
PT
Figure 1
35
AC
Figure 2
CE
PT
ED
MA NU
SC
RI P
T
ACCEPTED MANUSCRIPT
36
AC
CE
PT
ED
MA NU
SC
RI P
T
ACCEPTED MANUSCRIPT
37
PT
ED
MA NU
SC
RI P
T
ACCEPTED MANUSCRIPT
AC
CE
Figure 4
38
ED
MA NU
SC
RI P
T
ACCEPTED MANUSCRIPT
AC
CE
PT
Figure 5
39
ED
MA NU
SC
RI P
T
ACCEPTED MANUSCRIPT
AC
CE
PT
Figure 6
40